单位：万元 | 非经营性资金占用 | 资金占用 | 占用方与上 | 上市公司核 | 年期初占 2023 | 2023 年半年度 | 2023 年半年度 | 2023 年半年 | 2023 年半年度 | 占用形成 | 占用性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 方名称 | 市公司的关 | 算的会计科 | 用资金余额 | 占用累计发生金 | 占用资金的利 | 度偿还累计 | 末占用资金余 | 原因 | | | | | 联关系 | 目 | | 额（不含利息） | 息(如有) | 发生金额 | 额 | | | | 控股股东、实际控制 | 无 | | | | | | | | | | | 人及其附属企业 | | | | | | | | | | | | 前控股股东、实际控 | 无 | | | | | | | | | | | 制人及其附属企业 | | | | | | | | | | | | 其他关联方及附属 | 无 | | | | | | | | | | | 企业 | | | | | | | | | | | | ...

北方长龙新材料技术股份有限公司 证券代码：301357 证券简称：北方长龙 公告编号：2023-052 第二届监事会第二次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 具体内容详见公司同日在中国证监会指定的创业板信息披露网站巨潮资讯 网（www.cninfo.com.cn）上发布的《2023 年半年度报告》及《2023 年半年度报 告摘要》。 表决结果：3 票同意；0 票反对；0 票弃权。 2、审议通过《关于 2023 年半年度募集资金存放与使用情况的专项报告的议 案》 经审核，监事会认为：公司编制的《2023 年半年度募集资金存放与使用情况 的专项报告》客观、真实、准确地反映了公司 2023 年上半年募集资金存放与使 用的实际情况，公司按照相关规定使用募集资金，并及时、真实、准确、完整地 第 1 页 履行了相关信息披露工作。 一、监事会召开情况 北方长龙新材料技术股份有限公司（以下简称"公司"）第二届监事会第二 次会议通知于2023年8月24日通过现场、电话、电子邮件方式发出，会议于2023 年8月28日在公司会议室以现场表决的方式召开。本次 ...

证券代码：301357 证券简称：北方长龙 公告编号：2023-028 北方长龙新材料技术股份有限公司 关于参加"2023 年陕西辖区上市公司投资者集体接待日 暨 2022 年度业绩说明会"的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 为促进上市公司规范运作、健康发展，增强上市公司信息透明度，加强与广 大投资者沟通交流，进一步提升投资者关系管理水平，陕西上市公司协会根据陕 西证监局工作部署，联合深圳市全景网络有限公司举办"2023 年陕西辖区上市 公司投资者集体接待日暨 2022 年度业绩说明会活动"。 记载、误导性陈述或重大遗漏。 届时，公司董事长及相关高管人员将通过互动平台与投资者进行网络沟通和 交流，欢迎广大投资者踊跃参加！ 一、会议基本情况 1、活动时间：2023 年 5 月 16 日 15:00-17:00。 2、活动地址："全景路演" 3、网址：http://rs.p5w.net。 4、投资者问题征集渠道为： https://ir.p5w.net/zj；或扫描下方二维码进行提 问，公司将在说明会上对投资者关注的问题进行回答。 第 1 页 ...

Financial Performance - The company's revenue for Q1 2023 was ¥50,134,214.35, a decrease of 9.12% compared to ¥55,166,656.74 in the same period last year[5] - Net profit attributable to shareholders was ¥17,763,133.33, down 21.81% from ¥22,719,073.48 year-on-year[5] - Total operating revenue for Q1 2023 was ¥50,134,214.35, a decrease of 9.3% compared to ¥55,166,656.74 in Q1 2022[17] - Net profit for Q1 2023 was ¥17,763,133.33, down 21.8% from ¥22,719,073.48 in Q1 2022[18] - The total comprehensive income for the first quarter was CNY 17,763,133.33, a decrease from CNY 22,719,073.48 in the previous period, representing a decline of approximately 21.5%[19] Earnings and Shares - Basic and diluted earnings per share decreased by 22.22% to ¥0.35 from ¥0.45 in the same period last year[5] - Basic and diluted earnings per share for the quarter were both CNY 0.35, down from CNY 0.45 in the same period last year, reflecting a decrease of 22.2%[19] Cash Flow - The net cash flow from operating activities was negative at -¥28,854,960.20, a decline of 236.23% compared to ¥21,181,119.54 in the previous year[5] - Cash inflows from operating activities totaled CNY 16,042,237.45, significantly lower than CNY 38,364,915.19 in the previous year, indicating a decline of about 58.2%[22] - The net cash flow from operating activities was negative at CNY -28,854,960.20, compared to a positive CNY 21,181,119.54 in the prior year[22] - Cash inflows from financing activities were CNY 17,302,703.46, down from CNY 60,351,052.96 in the previous year, a decrease of about 71.4%[22] - The net cash flow from financing activities was CNY 10,489,604.83, significantly lower than CNY 58,644,420.60 in the previous year, indicating a decline of approximately 82.1%[22] - The ending cash and cash equivalents balance was CNY 58,666,128.09, down from CNY 67,432,701.72 in the previous year, reflecting a decrease of about 13.0%[22] Assets and Liabilities - Total assets increased by 4.65% to ¥746,996,423.53 from ¥713,796,812.09 at the end of the previous year[5] - Total liabilities increased to ¥336,239,605.85, compared to ¥320,803,127.74 in the previous year[15] - The company's cash and cash equivalents decreased by 31.62% to ¥63,890,397.13 from ¥93,433,429.46 at the beginning of the year[8] - Accounts receivable rose to ¥255,843,909.77, an increase of 8.4% from ¥236,222,893.40 in Q1 2022[15] - Inventory increased to ¥22,119,667.43, up from ¥17,416,443.28 in the previous year, indicating a 27% rise[15] Research and Development - The company reported a significant increase in research and development expenses, which rose by 31.98% to ¥6,797,469.75 from ¥5,150,502.15 year-on-year[9] - Research and development expenses rose to ¥6,797,469.75, an increase of 31.9% compared to ¥5,150,502.15 in the same period last year[18] Tax and Other Income - The company reported a decrease in tax expenses to ¥2,180,691.67 from ¥3,289,723.26, reflecting a 33.7% reduction[18] - The company received government subsidies amounting to ¥1,000,000.00, contributing to other income growth of 93.12%[9] Audit Status - The first quarter report was not audited[23]

Financial Performance - The company's operating revenue for 2022 was ¥250,222,638.95, a decrease of 12.95% compared to ¥287,453,630.73 in 2021[20]. - The net profit attributable to shareholders for 2022 was ¥80,020,515.55, down 26.32% from ¥108,601,535.62 in 2021[20]. - The basic earnings per share for 2022 was ¥1.57, reflecting a decline of 26.29% from ¥2.13 in 2021[20]. - The total net profit after deducting non-recurring gains and losses for 2022 was ¥77,801,384.94, a decrease of 26.05% from ¥105,210,655.09 in 2021[20]. - The gross profit margin for the other manufacturing industry segment was 57.07%, down 5.36% year-on-year[115]. - Revenue from military vehicle human-machine interface systems accounted for 88.66% of total revenue, totaling CNY 221.84 million, a decline of 17.01% year-on-year[112]. - Revenue from military vehicle supporting equipment increased by 41.01% to CNY 28.38 million, representing 11.34% of total revenue[112]. - The company reported a total of ¥23,773,358.77 in R&D expenses for 2022, a slight increase of 0.33% year-on-year[122]. - The company experienced a 32.88% reduction in sales expenses, primarily due to a decrease in after-sales service costs[122]. - The company reduced its management expenses by 17.71%, attributed to policy-related rent reductions and adjustments in the salary structure[122]. Cash Flow and Investments - The net cash flow from operating activities for 2022 was ¥51,234,296.97, a decrease of 6.28% compared to ¥54,664,618.43 in 2021[20]. - Operating cash inflow totaled ¥151,391,632.99, a decrease of 12.33% compared to ¥172,693,046.59 in 2021[126]. - Investment cash inflow increased significantly by 101.40% to ¥302,646,523.74, while investment cash outflow rose by 76.71% to ¥428,036,944.25[126]. - The net cash flow from financing activities surged by 158.36% to ¥123,810,727.69, primarily due to increased long-term borrowings for new base construction[127]. - The company's cash and cash equivalents increased by 367.09% to ¥49,654,604.15, compared to ¥10,630,575.20 in 2021[126]. - The company reported a total investment of ¥105,673,884.26 during the period, a decrease of 18.23% compared to the previous year's investment[134]. Market and Industry Outlook - The company plans to continue expanding its market presence and invest in new product development to drive future growth[20]. - The military industry is experiencing significant opportunities due to ongoing reforms and modernization efforts within the Chinese military[38]. - The military industry in China is increasingly integrating civilian enterprises, enhancing the overall capabilities and technological advancements in defense[30]. - The company faces increasing market competition as more private composite material manufacturers enter the military supply sector, potentially intensifying competition[153]. - The company anticipates a faster iteration cycle for military products, which may lead to reduced order volumes if it fails to engage in early-stage research projects[154]. Governance and Management - The company has established a comprehensive internal governance structure, including an audit committee, nomination committee, compensation and assessment committee, and strategic committee[161]. - The board of directors consists of 7 members, including 3 independent directors, and operates through specialized committees to ensure effective governance[161]. - The company maintains complete independence in assets, personnel, finance, and operations from its controlling shareholder[163][164][165][166][167]. - The company has a diverse board with members having backgrounds in various fields, including finance, management, and engineering[172][173][174][175][176]. - The independent director, Zhao Tong, has a strong academic background in polymer chemistry and has held significant positions in research institutions[175]. Research and Development - The company has established a research and production system focused on high-performance composite materials, enhancing the mobility, safety, reliability, and environmental adaptability of military equipment[53]. - The company has ongoing R&D projects aimed at expanding its product line, including new human-machine interface systems for various military vehicles[123]. - The company plans to enhance its product line in the military vehicle sector, developing systems for electronic information and armored vehicles, as well as auxiliary and protective products[145]. - The company is committed to developing new materials for military applications, focusing on non-metal composite materials[196]. - The company has a high-level R&D team with extensive industry experience, contributing to its competitive advantage in the military materials sector[108]. Shareholder and Dividend Information - The company plans to distribute a cash dividend of 5.88 RMB per 10 shares to all shareholders, based on a total of 68,000,000 shares[3]. - The cash dividend represents 16.46% of the total distributable profit of 242,946,517.23 CNY[197]. - The profit distribution proposal is subject to approval by the shareholders' meeting, indicating potential uncertainty[198]. - The total remuneration for directors, supervisors, and senior management in 2022 amounted to 4.7342 million yuan[182]. - The company has implemented an employee incentive plan to enhance management cohesion and competitiveness[200].

北方长龙新材料技术股份有限公司 上市公告书 北方长龙新材料技术股份有限公司 （North Long Dragon New Materials Tech Co., Ltd.） （陕西省西安市国家民用航天产业基地航天东路 699 号军民融合创新园（B 区）11 栋 2 层） 股票简称：北方长龙 股票代码：301357 北方长龙新材料技术股份有限公司 上市公告书 特别提示 首次公开发行股票并在创业板上市 之 上市公告书 保荐人（主承销商） （广东省广州市黄埔区中新广州知识城腾飞一街 2 号 618 室） 二零二三年四月 1 北方长龙新材料技术股份有限公司（以下简称"公司"、"本公司"、"发 行人"或"北方长龙"）股票将于 2023 年 4 月 18 日在深圳证券交易所创业板上 市。 创业板公司具有业绩不稳定、经营风险高、退市风险高等特点，投资者面临 较大的市场风险。投资者应充分了解创业板市场的投资风险及本公司所披露的风 险因素，审慎作出投资决定。 本公司提醒投资者应充分了解股票市场风险以及本公司披露的风险因素，在 新股上市初期切忌盲目跟风"炒新"，应当审慎决策、理性投资。 如无特别说明，本上市公告书中的简称或名词的 ...

北方长龙新材料技术股份有限公司 首次公开发行股票并在创业板上市发行结果公告 保荐人（主承销商）：广发证券股份有限公司 特别提示 北方长龙新材料技术股份有限公司（以下简称"北方长龙"或"发行人"）首次 公开发行人民币普通股（A 股）（以下简称"本次发行"）并在创业板上市的申请 已经深圳证券交易所（以下简称"深交所"）创业板上市委员会审议通过，并已经 中国证券监督管理委员会同意注册（证监许可〔2023〕460 号）。本次发行的保 荐人（主承销商）为广发证券股份有限公司（以下简称"保荐人（主承销商）"）。 发行人的股票简称为"北方长龙"，股票代码为"301357"。 发行人和保荐人（主承销商）协商确定本次发行的发行价格为 50.00 元/股， 发行数量为 1,700.00 万股。本次发行全部为公开发行新股，公司股东不进行公开 发售股份。 本次发行的发行价格不超过剔除最高报价后网下投资者报价的中位数和加 权平均数以及剔除最高报价后通过公开募集方式设立的证券投资基金（以下简称 "公募基金"）、全国社会保障基金（以下简称"社保基金"）、基本养老保险基金 （以下简称"养老金"）、企业年金基金和职业年金基金（以下简称"年金基 ...

创业板投资风险提示 本次发行股票拟在创业板上市，创业板公司具有创新投入大、新旧产业融合存 在不确定性、尚处于成长期、经营风险高、业绩不稳定、退市风险高等特点，投资 者面临较大的市场风险。投资者应充分了解创业板市场的投资风险及本公司所披露 的风险因素，审慎作出投资决定。 北方长龙新材料技术股份有限公司 （North Long Dragon New Materials Tech Co., Ltd.） （陕西省西安市国家民用航天产业基地航天东路 699 号军民融合创新园(B 区)11 栋 2 层） 首次公开发行股票并在创业板上市 招股说明书 保 荐 人： 广东省广州市黄埔区中新广州知识城腾飞一街 2 号 618 室 主承销商： 北方长龙新材料技术股份有限公司 招股说明书 声 明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断 ...

北方长龙新材料技术股份有限公司 首次公开发行股票并在创业板上市发行公告 保荐人（主承销商）：广发证券股份有限公司 特别提示 北方长龙新材料技术股份有限公司（以下简称"北方长龙"、"发行人"或"公司"） 根据《证券发行与承销管理办法》（证监会令〔第 208 号〕，以下简称《管理办法》 " "）、 《首次公开发行股票注册管理办法》（证监会令〔第 205 号〕）、《深圳证券交易所首 次公开发行证券发行与承销业务实施细则》（深证上〔2023〕100 号，以下简称"《业 务实施细则》"）、《深圳市场首次公开发行股票网上发行实施细则》（深证上〔2018〕 279 号，以下简称"《网上发行实施细则》"）、《深圳市场首次公开发行股票网下发 行实施细则（2023 年修订）》（深证上〔2023〕110 号，以下简称"《网下发行实施 细则》"）、《首次公开发行证券承销业务规则》（中证协发〔2023〕18 号）、《首次公 开发行证券网下投资者管理规则》（中证协发〔2023〕19 号，以下简称"《网下投 资者管理规则》"）以及深圳证券交易所（以下简称"深交所"）有关股票发行上市规 则和最新操作指引等有关规定组织实施首次公开发行股票并在 ...

北方长龙新材料技术股份有限公司 （North Long Dragon New Materials Tech Co., Ltd.） （陕西省西安市国家民用航天产业基地航天东路 699 号军民融合创新园(B 区)11 栋 2 层） 首次公开发行股票并在创业板上市 创业板投资风险提示 本次发行股票拟在创业板上市，创业板公司具有创新投入大、新旧产业融合存 在不确定性、尚处于成长期、经营风险高、业绩不稳定、退市风险高等特点，投资 者面临较大的市场风险。投资者应充分了解创业板市场的投资风险及本公司所披露 的风险因素，审慎作出投资决定。 招股意向书 保 荐 人： 主承销商： 广东省广州市黄埔区中新广州知识城腾飞一街 2 号 618 室 北方长龙新材料技术股份有限公司 招股意向书 声 明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对发行 人注册申请文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其 对发行人的盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任 何与之相反的声明均属虚假不实陈述。 根据《证券法》规定，股票依法发行后，发行人经营与收益的变化，由发行 人自行负责；投资者自主判断 ...